ALKEM
Alkem Laboratories Limited Fundamentals
Alkem Laboratories Limited , a pharmaceutical organization, creates, fabricates, and sells drug and nutraceutical items in India and universally. The organization offers marked generics, nonexclusive medications, dynamic drug fixings, and nutraceuticals in intense and constant remedial regions containing against infective, dermatology, diabetology, cardiology, gastroenterology, osteoporosis, focal sensory system, oncology, urology, and gynecology, just as nutrients, minerals, and supplements; and help with discomfort/pain relieving, hostile to diabetic, and nervous system science items. It likewise gives pregnancy discovery packs and condoms. Alkem Labs Restricted was consolidated in 1973 and is settled in Mumbai, India.
Business space of the organization
The organization is one of India's principal worldwide drug organization. The organization is occupied with the turn of events, production and advertising of drugs with functional impressions across various nations. In India, it has a considerable presence in a few treatment sections and reliably includes among the main ten drug organizations. Guided by its industry experience of more than forty years, it offers excellent marked generics, nonexclusive medications, dynamic drug fixings and nutraceuticals.
Awards and Recognition
2016:
- Won the ''HR Tech Award for Best use of Technology in Human Resources'' by World HRD Congress.
- Won the Best Demand Planning and Forecasting Company - Pharmaceutical by ISCM''s - SCMPro''s in Demand Planning and Forecasting Forum Awards 2016.
- Alkem-Pentacare division won the most enterprising company in leveraging technology in use of Mobile Applications by DigiPharmaX.
- Brand ''Pan'' received ‘Brand of the Year'' award in sub-chronic category at AWACS Awards, 2016.
- Alkem won the Guinness World Record for creating largest Blister Pack Mosiac at RSSDI Hyderabad.
2017
- Alkem Corporate Video won the 1st runners up award in the Best Corporate Film for driving Employee Engagement initiatives in the Mega Corporate Film Festival and Awards held in Mumbai.
- Received the Best Stand-out IR award 2017 by IR Society India in association with KPMG and Bloomberg.
- Won the People Matters league Awards - Learning & Development 2017 - Best in Cultural Transformation in Mumbai.
- Won the Guinness world Records for creating largest Bindi Mosiac at RSSDI Bhubaneswar.
- Won the Rising Digital Star of the Year for various digital initiatives by DigiPharmaX Awards 2017.
2018
- Best Innovative CSR Project at CSR Summit & Awards 2018.
- Brand ‘Clavam’ received Brand of the Year 2018 Award at AWACS Awards for marketing excellence.
- Business Excellence Award 2018 for Best Range of ICU Products, Pharma and Health Care Summit organized by CIMS (Current Index of Medical Specialties).
2019
- Express Pharma Excellence Award at Pharma CXO Summit 2011.
- Best Use of Technology in Sales Hiring by Global Eminence Digital Awards sponsored by AQUILAA.
2020
- CIO Conclave and Awards 2020 in the category ‘Best IT Team of the year’.
- Alkem Laboratories as Great Place to Work-Certified organization in the large organization category across industries.
- India''s Best Workplaces in Biotechnology & Pharmaceuticals.
Milestones
1973: Inception of Alkem Laboratories.
1978: First manufacturing unit was established at Taloja near Mumbai.
1992: Second manufacturing facility established at Mandva, Gujarat which was converted into an API facility in 2005.
2003: First research and development facility established at Taloja.
2006: Taxim became India’s first anti-infective drug to surpass annual sales figure of ` 1,000 million in the domestic market.
2007: Filed the first ANDA in the United States for the drug Amlodipine.
2009: Received the first ANDA approval in the United States for the drug Amlodipine.
2009: Acquired Pharmacor Pty. Ltd., a generic pharmaceutical company in Australia.
2010: Acquired Ascend Laboratories, pharmaceutical company in the United States.
2011: Acquired Enzene, a company engaged in the development of biosimilars in India.
2012: Acquired an API manufacturing facility in the United States.
2014: Acquired the ‘Clindac-A’ brand in India from Galderma S.A.
2014: Clavam surpassed Rs 2,000 million domestic sales figure.
2015: Acquired a formulation manufacturing facility in the United States.
2015: Successfully completed Initial Public Offering (IPO).
2018: Revenue from the US market crossed $ 200 million in annual sales.
2019: Crossed the revenue milestone of $1 billion.
ALKEM Limited Stock Price Analysis and Quick Research Report
Let’s scrutinize however ALKEM is acting and if it's the proper time to buy the stock of ALKEM with careful analysis.
Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 1,324.48 Cr.
Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Alkem Laboratories has a Debt to Equity ratio of 0.18 , which is a strong indication for the company.
EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Alkem Laboratories, the EPS growth was 33.27 % which is good for the company.
Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Alkem Laboratories has OPM of 26.99 % which is a good sign for profitability.
ROE: Alkem Laboratories have a healthy ROE of 24.23 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
NOTE: We might update this page with latest updates/information/news etc if it deems to be necessary.
Thank You